Table 5.
Stigma, provider knowledge, and substance use co-treatment among providers treating HCV (N = 153)
| Stigma Observed by Providers | n | % |
|---|---|---|
| Healthcare workers unwilling to care for a person with HCV | 7 | 5% |
| Provision of poorer quality of care | 12 | 8% |
| Colleagues talking badly about persons with HCV | 11 | 7% |
| Provider Knowledge | ||
| Topics most uncomfortable discussing | ||
| Insurance coverage of HCV medications and support | 81 | 57% |
| Medication drug interactions | 74 | 50% |
| Treatment safety and side effects | 49 | 33% |
| Topics most comfortable discussing | ||
| HCV testing | 147 | 99% |
| HCV treatment efficacy | 124 | 84% |
| Liver fibrosis testing | 122 | 82% |
| Supports and Resources used most | ||
| Colleagues with experience | 102 | 67% |
| Pharmacists | 94 | 61% |
| Clinical Guidelines | 81 | 53% |
| Online tutorials | 67 | 44% |
| Project ECHO | 60 | 39% |
| Treating HCV in persons with Substance Use | ||
| Willing to treat HCV in those actively using | ||
| Drugs | 136 | 94% |
| Alcohol | 134 | 95% |
| Concerns when treating | ||
| Medication adherence | 132 | 92% |
| Patient mental health | 131 | 91% |
| Patient stability | 137 | 95% |
| Providers treating HCV willingness to prescribe medications for substance use disorders | 54 | 60% |
| Provider located in Puget Sound region | 38 | 70% |
aResponses from 90 providers treating HCV in persons actively using alcohol or drugs